Population-based study of cystic fibrosis disease severity and haemochromatosis gene mutations

Respirology

Volumn 15, Issue 1, 2010, Pages 141-149

  Pratap, Upasna ^a   Quinn, Stephen ^a   Blizzard, Leigh B ^a   Reid, David W ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Cystic fibrosis; Haemochromatosis; Iron; Pseudomonas aeruginosa

Indexed keywords

HFE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GENE MUTATION; HUMAN; INFANT; INTESTINE OBSTRUCTION; IRON STORAGE; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MECONIUM ILEUS; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; SCHOOL CHILD;

ADOLESCENT; ADULT; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMEOSTASIS; HUMANS; IRON; MALE; MEMBRANE PROTEINS; MUTATION; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEVERITY OF ILLNESS INDEX; TASMANIA; YOUNG ADULT;

EID: 74049159449     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01649.x     Document Type: Article

References (31)

1. Pietrangelo A. Haemochromatosis. Gut 2003 52 (Suppl. 2 ii23 30.
2. Acton JD, Wilmott RW. Phenotype of CF and the effects of possible modifier genes. Paediatr. Respir. Rev. 2001 2 : 332 339.
3. Fleming RE, Britton RS, Waheed A et al. Pathophysiology of hereditary hemochromatosis. Semin. Liver Dis. 2005 25 : 411 419.
4. Davies JC, Griesenbach U, Alton E. Modifier genes in cystic fibrosis. Pediatr. Pulmonol. 2005 39 : 383 391.
5. Buscher R, Grasemann H. Disease modifying genes in cystic fibrosis: therapeutic option or one-way road? Naunyn Schmiedebergs Arch. Pharmacol. 2006 374 : 65 77.
6. Merlo CA, Boyle MP. Modifier genes in cystic fibrosis lung disease. J. Lab. Clin. Med. 2003 141 : 237 241.
7. Brazova J, Sismova K, Vavrova V et al. Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clin. Immunol. 2006 121 : 350 357.
8. Buranawuti K, Boyle MP, Cheng S et al. Variants in mannose-binding lectin and tumor necrosis factor {alpha} affect survival in cystic fibrosis. J. Med. Genet. 2007 44 : 209 214.
9. Carlsson M, Sjoholm AG, Eriksson L et al. Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship. Clin. Exp. Immunol. 2005 139 : 306 313.
10. Davies JC, Turner MW, Klein N. Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles. Eur. Respir. J. 2004 24 : 798 804.
11. Devaney J, Maher M, Smith T et al. HFE alleles in an Irish cystic fibrosis population. Genet. Test. 2003 7 : 155 158. (Pubitemid 36842207)
12. Rohlfs EM, Shaheen NJ, Silverman LM. Is the hemochromatosis gene a modifier locus for cystic fibrosis? Genet. Test. 1998 2 : 85 8.
13. Reid DW, Carroll V, O'May C et al. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis. Eur. Respir. J. 2007 30 : 286 292.
14. Reid DW, Lam QT, Schneider H et al. Airway iron and iron-regulatory cytokines in cystic fibrosis. Eur. Respir. J. 2004 24 : 286 291.
15. Reid DW, Withers NJ, Francis L et al. Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection. Chest 2002 121 : 48 54.
16. Stites SW, Plautz MW, Bailey K et al. Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis. Am. J. Respir. Crit. Care Med. 1999 160 : 796 801.
17. Moreau-Marquis S, Bomberger JM, Anderson GG et al. The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am. J. Physiol. Lung Cell Mol. Physiol. 2008 295 : L25 37.
18. Cauza E, Hanusch-Enserer U, Bischof M et al. Increased C282Y heterozygosity in gestational diabetes. Fetal Diagn. Ther. 2005 20 : 349 354.
19. Malecki MT, Klupa T, Walus M et al. A search for association between hereditary hemochromatosis HFE gene mutations and type 2 diabetes mellitus in a Polish population. Med. Sci. Monit. 2003 9 : BR91 95.
20. Wittmann I, Wagner L, Marko L et al. Importance of hereditary haemochromatosis in the care of diabetes mellitus Orv. Hetil. 2007 148 : 111 115.
21. Peterlin B, Globocnik Petrovic M, Makuc J et al. A hemochromatosis- causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes. J. Hum. Genet. 2003 48 : 646 649. (Pubitemid 38031308)
22. Moczulski DK, Grzeszczak W, Gawlik B. Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy. Diabetes Care 2001 24 : 1187 1191.
23. Johnson C, Butler SM, Konstan MW et al. Factors influencing outcomes in cystic fibrosis: a center-based analysis. Chest 2003 123 : 20 7.
24. O'Connor GT, Quinton HB, Kahn R et al. Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr. Pulmonol. 2002 33 : 99 105.
25. Mueller-Brandes C, Holl RW, Nastoll M et al. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis. Eur. Respir. J. 2005 25 : 715 717.
26. Khalid S, McGrowder D, Kemp M et al. The use of soluble transferrin receptor to assess iron deficiency in adults with cystic fibrosis. Clin. Chim. Acta 2007 378 : 194 200.
27. Lucotte G. Frequency analysis and allele map in favor of the celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol. Dis. 2001 27 : 549 556.
28. Lucotte G, Mercier G. Celtic origin of the C282Y mutation of hemochromatosis. Genet. Test. 2000 4 : 163 169.
29. Reid DW, Anderson GJ, Lamont IL. Cystic fibrosis: ironing out the problem of infection? Am. J. Physiol. Lung Cell Mol. Physiol. 2008 295 : L23 24.
30. Allen KJ, Gurrin LC, Constantine CC et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N. Engl. J. Med. 2008 358 : 221 230.
31. Moran A. Cystic fibrosis-related diabetes: an approach to diagnosis and management. Pediatr. Diabetes 2000 1 : 41 8.